Clinical trial
The Copenhagen Translational Skin Immunology Biobank and Research Program - BIOSKIN: Methotrexat to Hand Eczema
NCT07338305 is registered in ClinicalTrials.gov with Lone Skov as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Copenhagen Translational Skin Immunology Biobank and Research Program - BIOSKIN: Methotrexat to Hand Eczema
- Lead sponsor
- Lone Skov
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- November 1, 2025
- Completion date
- December 31, 2026
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atopic dermatitis, contact dermatitis, hand eczema